TNMSRA urges Centre to not levy GST on medicines, medical equipment
Madurai: Members of the Tamil Nadu Medical and Sales Representatives Association (TNMSRA) urged the Centre to refrain from…
TNMSRA urges Centre to not levy GST on medicines, medical equipment
Members of the Tamil Nadu Medical and Sales Representatives Association (TNMSRA) urged the Centre to refrain from levying…
‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs | Weight-loss drugs
The high cost of weight-loss medication is a “regressive tax on being thin” because the outlay outweighs any…
FDA Approves Drug for Narcolepsy – The Presidential Prayer Team
An official says this is the first drug that addresses the underlying biology of the disease. The Food…
Kratom’s growing popularity raises questions over benefits and risks
COLORADO SPRINGS, Colo. (KKTV) – A plant native to Southeast Asia is gaining popularity in the U.S., including…
Beware of people claiming to be our agents: Maha FDA
The Maharashtra Food and Drug Administration (FDA) on Thursday said it has not appointed any agent, intermediary, third…
Eli Lilly CEO ‘definitely wants Mounjaro to be listed on the PBS’
News
Despite walking away from the deal earlier this year and price negotiations stalling, the drug’s…
Krock Chiropractic opens in Franklin | Business
FRANKLIN – Krock Chiropractic officially celebrated their grand opening on Friday, Aug. 7, with a ribbon-cutting ceremony in…
Homoeopaths Can’t Practice Other System Of Medicine: Homoeopathy Panel
New Delhi: The National Commission for Homoeopathy (NCH) has said that homoeopathic practitioners cannot practice any other system…
EXCLUSIVE: Drug companies choosing not to sell life-saving and life-extending medicines in Canada
When Ruchi Ambike found out that Novartis got Health Canada approval for Vanrafia she was ecstatic. The drug…
GLP-1 Bridge Program patient has difficulty getting medication
GLP-1 Bridge Program patient has difficulty getting medication GLP-1 Bridge Program Patient has difficulty getting medication Some Medicare…
Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (14 August 2026) approved vimseltinib (romvimza) to treat adult patients with tenosynovial…